Mayinglong Pharmaceutical Group Co (SHSE:600993) FFO per Share

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

SHSE:600993 Mayinglong Pharmaceutical Group Co Ltd SHSE:600993
93 GF Score
Price ¥24.01
GF Value ¥29.63
Valuation Modestly Undervalued
! 1 Warning Sign
View Full Analysis

What is Mayinglong Pharmaceutical Group Co FFO per Share?

FFO per Share only applies to REITs.

SHSE:600993
93GF Score
Mayinglong Pharmaceutical Group Co Ltd SHSE:600993
FFO per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Mayinglong Pharmaceutical Group Co (SHSE:600993) Overvalued in 2026?

Based on GuruFocus' analysis, Mayinglong Pharmaceutical Group Co stock appears to be undervalued. The current stock price of ¥24.01 is trading 19% below its estimated GF Value™ of ¥29.63. GuruFocus considers Mayinglong Pharmaceutical Group Co to be Modestly Undervalued.

Key valuation signals for SHSE:600993:

  • FFO per Share:
  • GF Value™: ¥29.63 vs. price of ¥24.01 (19% below fair value)
  • GF Score™: 93/100 with 1 warning sign

No single metric tells the full story. See the SHSE:600993 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Mayinglong Pharmaceutical Group Co Business Description

Address No. 100 Zhoujiawan, Nanhu, Wuchang District, Wuhan, Hubei, CHN, 430064
Mayinglong Pharmaceutical Group Co Ltd is a China-based company mainly involved in pharmaceutical development, retailing and wholesaling. The company provides ointments, suppositories, and tablets for hemorrhoids.
93GF Score

Get the complete analysis for SHSE:600993

FFO per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

¥24.01
Price
¥29.63
GF Value